Pages that link to "Q34333002"
Jump to navigation
Jump to search
The following pages link to New cytotoxic agents and schedules for advanced breast cancer (Q34333002):
Displaying 6 items.
- Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines (Q24650717) (← links)
- A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer (Q33244593) (← links)
- Platinum-based chemotherapy in metastatic breast cancer: current status. (Q35650449) (← links)
- Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines (Q37355092) (← links)
- Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase (Q44025397) (← links)
- Weekly Paclitaxel Combining with Gemcitabine is an Effective and Safe Treatment for Advanced Breast Cancer Patients (Q83069884) (← links)